The DOI matches its Crossref record; 278 of the 288 references it cites were found in a registry or an index.
Multiple aberrations in shared inflammatory and oxidative & nitrosative stress (IO&NS) pathways explain the co-association of depression and cardiovascular disorder (CVD), and the increased risk for CVD and due mortality in depressed patients
Abstract
There is evidence that there is a bidirectional relationship between major depression and cardiovascular disorder (CVD): depressed patients are a population at risk for increased cardiac morbidity and mortality, and depression is more frequent in patients who suffer from CVD. There is also evidence that inflammatory and oxidative and nitrosative stress (IO&NS) pathways underpin the common pathophysiology of both CVD and major depression. Activation of these pathways may increase risk for both disorders and contribute to shared risk. The shared IO&NS pathways that may contribute to CVD and depression comprise the following: increased levels of pro-inflammatory cytokines, like interleukin-1β (IL-1β), IL-2, IL-6, IL-8, IL-12, tumor necrosis factor-α, and interferon-γ; T cell activation; increased acute phase proteins, like C-reactive protein, haptoglobin, fibrinogen and α1-antitrypsin; complement factors; increased LPS load through bacterial translocation and subsequent gut-derived inflammation; induction of indoleamine 2,3-dioxygenase with increased levels of tryptophan catabolites; decreased levels of antioxidants, like coenzyme Q10, zinc, vitamin E, glutathione and glutathione peroxidase; increased O&NS characterized by oxidative damage to low density lipoprotein (LDL) and phospholipid inositol, increased malondialdehyde, and damage to DNA and mitochondria; increased nitrosative stress; and decreased ω3 polyunsaturated fatty acids (PUFAs). The complex interplay between the abovementioned IO&NS pathways in depression results in pro-atherogenic effects and should be regarded as a risk factor to future clinical CVD and due mortality. We suggest that major depression should be added as a risk factor to the Charlson "comorbidity" index. It is advised that patients with (sub)chronic or recurrent major depression should routinely be assessed by serology tests to predict if they have an increased risk to cardiovascular disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Considering that the presence of oxidative (and nitrosative) stress may cause neurodegeneration and reduced neurogenesis [63, 64]”
From Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder (2012) · cites this paper as [63]
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration
Qin, L., Wu, X., Block, M. L., Liu, Y., Breese, G. R., Hong, J., Knapp, D. J., & Crews, F. T. (2007) · Glia · doi:10.1002/glia.20467 · Cited by 2,144
Defining Comorbidity: Implications for Understanding Health and Health Services
Valderas, J. M., Starfield, B. H., Sibbald, B., Salisbury, C., & Roland, M. O. (2009) · The Annals of Family Medicine · doi:10.1370/afm.983 · Cited by 1,730
Psychopharmacology: The Fourth Generation of Progress
Brophy, J. J. (1995) · JAMA · doi:10.1001/jama.1995.03530220079046 · Cited by 1,582
The pre-therapeutic classification of co-morbidity in chronic disease
Feinstein, A. R. (1970) · Journal of Chronic Diseases · doi:10.1016/0021-9681(70)90054-8 · Cited by 1,544
MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions
Gerszten, R. E., García-Zepeda, E. A., Lim, Y.-C., Yoshida, M., Ding, H. A., Gimbrone, M. A., Luster, A. D., Luscinskas, F. W., & Rosenzweig, A. (1999) · Nature · doi:10.1038/19546 · Cited by 1,242
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Self-citationMaes, M., Galecki, P., Chang, Y. S., & Berk, M. (2011) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.05.004 · Cited by 1,140
Self-citationEvidence for an immune response in major depression: A review and hypothesis
Maes, M. (1995) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)00101-m · Cited by 1,003
Self-citation
Flagged first, then by citations
10 of the 288 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Maes, 1998, Fatty acids, cytokines, and major depression, Biol Psychiatry, 43, 313
- Maes, 2007, Neuro Endocrinol Lett, 28, 861
Cited by
Sorted by citations
Items 101–165 of 165
Relationship between interleukin-1β and depressive disorder after acute coronary syndrome
Kang, H., Bae, K., Kim, S., Shin, I., Hong, Y. J., Ahn, Y., Jeong, M. H., Yoon, J., & Kim, J. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.09.001 · Cited by 18
Naß, J., Kampf, C. J., & Efferth, T. (2021) · Molecules · doi:10.3390/molecules26071827 · Cited by 17
Al‐Hakeim, H. K., Altufaili, M. F., Almulla, A. F., Moustafa, S. R., & Maes, M. H. J. (2022) · Cells · doi:10.3390/cells11223694 · Cited by 17
Self-citationVerma, H., Shivavedi, N., Tej, G. N. V. C., Kumar, M., & Nayak, P. K. (2022) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.23160 · Cited by 17
Bonifácio, K. L., Barbosa, D. S., Moreira, E. G., de Farias, C. C., Vargas, H. O., Nunes, S. O. V., Moraes, J. B., & Maes, M. H. J. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.040 · Cited by 17
Self-citationCockayne, N. L., Duffy, S. L., Bonomally, R., English, A., Amminger, G. P., Mackinnon, A. J., Christensen, H. M., Naismith, S. L., & Hickie, I. B. (2015) · Trials · doi:10.1186/s13063-015-0762-6 · Cited by 17
Liu, J., Liu, Z., Zhou, Y., Liu, Y., Weijian, S., Wang, N., Wu, L., Liu, X., Yin, X., Wang, Y., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.04.072 · Cited by 15
Huang, F., Mariani, N., Pariante, C. M., & Borsini, A. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100674 · Cited by 15
Liu, F., Meng, Y., Wang, R., Shen, S., Li, P., & He, F. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.05.159 · Cited by 15
Jaroonpipatkul, C., Onwanna, J., Tunvirachaisakul, C., Jittapiromsak, N., Rakvongthai, Y., Chutinet, A., Supasitthumrong, T., & Maes, M. H. J. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.04.041 · Cited by 15
Self-citationMoran, L., Wilson, C. J., Buckley, J. D., Noakes, M., Clifton, P. M., & Brinkworth, G. D. (2013) · Nutrition · doi:10.1016/j.nut.2013.03.023 · Cited by 14
Lucas, K., & Maes, M. H. J. (2013) · PubMed · doi:10.26187/deakin.33284208 · Cited by 14
Self-citationWang, W., Shi, Y., Zhang, J., Wang, Y., Wabo, T. M. C., Yang, Y., He, W., & Zhu, S. (2024) · Food & Function · doi:10.1039/d4fo00236a · Cited by 13
Glutamate cysteine ligase (GCL) and self reported depression: An association study from the HUNT
Berk, M., Johansson, S., Wray, N. R., Williams, L. J., Olsson, C. A., Haavik, J., & Bjerkeset, O. A. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.12.019 · Cited by 12
Self-citationRen, H., Sun, R., & Wang, J. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.5857 · Cited by 12
Genotoxicity and carcinogenicity of ivermectin and amoxicillin in vivo systems
de Sousa, F. A., de Morais, C. R., Vieira, J. S., Maranho, L. S., Machado, F. L., Pereira, S. M., Barbosa, L. C., Coelho, H. E., Campos, C. F., & Bonetti, A. M. (2019) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2019.103196 · Cited by 12
Shared neuroimmune and oxidative pathways underpinning Chagas disease and major depressive disorder
Duarte-Silva, E. P., Maes, M. H. J., Macêdo, D. S., Savino, W., & Peixoto, C. A. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-01105-9 · Cited by 12
Self-citationSynergistic effects of depression and NR3C1 methylation on prognosis of acute coronary syndrome
Kang, H., Stewart, R. J., Kim, J., Kim, S.-W., Shin, I., Kim, M.-C., Hong, Y. J., Ahn, Y., Shin, M.-G., Jeong, M. H., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62449-2 · Cited by 12
Association of Leukocyte Telomere Length with Fatigue in Nondisabled Older Adults
Bendix, L., Thinggaard, M., Kimura, M., Aviv, A., Christensen, K., Osler, M., & Avlund, K. (2014) · Journal of Aging Research · doi:10.1155/2014/403253 · Cited by 10
Ye, C., Chen, G., Huang, W., & Liu, Y. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.12.041 · Cited by 9
The P2X7 receptor in depression: Novel insights and therapeutic implications
Zhong, Y.-T., Pi, C., Zuo, Y., Yan, W., Li, W., Jiang, Y., Lei, T., Zheng, W., Jiang, J., Yang, Y., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107011 · Cited by 11
Maes, M. H. J., Almulla, A. F., Stoyanov, D., & Zhang, Y. (2025) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2025.2608029 · Cited by 8
Self-citationJeon, Y. J., Cho, S. M. J., Lee, Y. J., Kim, H. C., & Jung, S. J. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.03.174 · Cited by 8
Predictive value of homocysteine for depression after acute coronary syndrome
Kang, H. J., Stewart, R. J., Bae, K. Y., Kim, S. W., Shin, I. S., Kang, H., Moon, W. J., Hong, Y. J., Ahn, Y., Jeong, M. H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11966 · Cited by 8
Zhang, L., Yin, J., Sun, H., Yang, J., & Liu, Y. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-074001 · Cited by 6
Li, H., & Long, L. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1519612 · Cited by 6
Psychoneuroimmunology of Depression
Yan, Q. (2016) · Springer eBooks · doi:10.1007/978-3-319-45111-4_6 · Cited by 6
Jirakran, K., Vasupanrajit, A., Tunvirachaisakul, C., Kubera, M., & Maes, M. (2023) · medRxiv · doi:10.1101/2023.02.10.23285746 · Cited by 6
Self-citationMousa, R., Smesam, H. N., Qazmooz, H. A., Hakeim, H. K. A., & Maes, M. (2020) · Preprints.org · doi:10.20944/preprints202009.0053.v1 · Cited by 6
Self-citationIs There a Link Between Cholesterol Level and the Risk of Developing Depression?
Broncel, M., & Serejko-Banaś, K. E. (2016) · Open Medicine Journal · doi:10.2174/1874220301603010352 · Cited by 5
Pan, G., Fu, Q., Xu, Y., & Jiang, L. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.01.038 · Cited by 4
Lian, K., Zhang, X., Shi, C., Yang, W., & Xu, X. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.01.135 · Cited by 4
Yan, Q., Liu, G., Wang, R., Li, D., & Wang, D. (2025) · Journal of Health Population and Nutrition · doi:10.1186/s41043-025-00890-7 · Cited by 3
Decoding Fibromyalgia: Genetic Insights into Gut and Immune System Interactions
Niu, M., Li, J., Sarafian, V. S., & Maes, M. H. J. (2025) · Journal of Pain Research · doi:10.2147/jpr.s525610 · Cited by 3
Self-citationTryptophan Metabolism in Human Diseases
Zhao, Y., Wang, L., Xiong, X., Gao, Y., & Zhou, H. (2024) · Springer eBooks · doi:10.1007/978-981-97-4719-1_5 · Cited by 3
Topçu, A., Yurtsever, İ., İşleyen, Z. S., Beşiroğlu, M., Yasin, A. İ., Topcu, Z. A., Shbair, A. T., Toluk, Ö., Şimşek, M., Şeker, M., et al. (2023) · Future Oncology · doi:10.2217/fon-2022-1200 · Cited by 2
Simeonova, D., Stoyanov, D., Leunis, J., Carvalho, A. F., Kubera, M., Murdjeva, M., & Maes, M. H. J. (2019) · Preprints.org · doi:10.20944/preprints201907.0293.v1 · Cited by 2
Self-citationKim, S., Choi, Y., & Kim, Y. S. (2024) · Mental health and physical activity · doi:10.1016/j.mhpa.2024.100662 · Cited by 1
Abd-elmonsif, N. M., Gamal, S., & Bahgat, B. M. (2026) · BMC Oral Health · doi:10.1186/s12903-026-07746-4 · Cited by 1
Exploración de un modelo de estadiaje clínico aplicado al trastorno bipolar
Tatay, A. (2015) · Dialnet (Universidad de la Rioja)
Mitochondrial Dysfunction and Physiological Depression
Raffelock, D. (2015) · CRC Press eBooks · doi:10.1201/b19089-7
Medical Comorbidity in the Course of Bipolar Disorder
Smith, P. M. (2016) · doi:10.12794/metadc849606
Levine, T. B., & Levine, A. B. (2012) · Wiley eBooks · doi:10.1002/9781118480045.ch7
Gesi, C., Carpita, B., Barberi, F. M., Cordone, A., & Dell’Osso, L. (2020) · Springer eBooks · doi:10.1007/978-3-319-90305-7_22-1
Depression and Vitamin D in Pregnancy
Lamb, A. (2014)
Joob, B., Yasri, S., & Wiwanitkit, V. (2021) · PubMed Central
Gesi, C., Carpita, B., Barberi, F. M., Cordone, A., & Dell’Osso, L. (2020) · Springer eBooks · doi:10.1007/978-3-030-28008-6_22
ศิริปัญญา, เ. (2017) · Chula Digiverse · doi:10.58837/chula.the.2017.1212
Zahid, A., Batool, A., Khan, M. A., Ahmad, A., Ullah, A., & Wajid, A. (2024) · Research Square · doi:10.21203/rs.3.rs-4684994/v1
Bariweni, M. W., Oboma, Y. I., & Samuel, E. (2022) · Journal of Reports in Pharmaceutical Sciences · doi:10.4103/jrptps.jrptps_122_21
Zahid, A., Batool, A., Khan, M. A., Ahmad, A., Ullah, A., & Wajid, A. (2024) · Research Square · doi:10.21203/rs.3.rs-4684994/v2
Majör Depresif Bozukluk ve Omega 3 Yağ Asitleri
Pehlivan, M., & Denkçi, N. (2025) · Balkan Sağlık Bilimleri Dergisi · doi:10.61830/balkansbd.1591747
Oxidative Stress in Cardiovascular Disorders
Goel, K., Chawla, I., Malik, G., & Dhanawat, M. (2025) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-7919-6.ch009
Li, Q., Cheng, S., Zhang, F., & Qi, X. (2025) · doi:10.2196/preprints.86449
He, Y., Hiutung, C., Tian, D., Han, Z., & Hu, W. (2025) · European journal of medical research · doi:10.1186/s40001-025-03360-2
Fernandez-Montero, A., Moreno‐Galarraga, L., Sánchez-Villegas, A., Lahortiga‐Ramos, F., Ruiz‐Canela, M., Martínez‐González, M. Á., & Molero, P. (2020) · Figshare · doi:10.6084/m9.figshare.12021807
Al‐Hakeim, H. K., Al-Hadrawi, D. S., Niu, M., & Maes, M. H. J. (2025) · medRxiv · doi:10.64898/2025.12.23.25342889
Self-citationHuang, P., Peng, W., Lu, J., Feng, Y., Zhang, G., & Chen, B. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.121096
Zhou, J., Jiang, S., Huang, H., Sun, X., Ye, G., Tang, Y., Wang, X., Deng, H., He, H., Luo, X., et al. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101220
Etude de la voie de la kynurénine dans la symptomatologie du sujet obèse
Huet, L. (2019) · theses.fr (ABES) · doi:10.70675/ff26d7c8z4c5fz4c86z9e6ezd8d843268447
Jiang, S., Zhou, S., Cui, P., Qiao, Y., Gao, Q., Du, Z., & Zhang, G. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120153
Sarsah, S. K., & Murray, M. N. (2026) · BMC Research Notes · doi:10.1186/s13104-026-07898-0
Metadata
- Authors
- Maes, M., Ruckoanich, P., Chang, Y. S., Mahanonda, N., & Berk, M.
- Affiliations
- Piyavate Hospital (TH)
- Mental Health Research Institute (AU)
- Corresponding author
- Maes, Michael
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2011-04
- Volume
- 35
- Issue
- 3
- Pages
- 769-783
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2011854518
- Cited by
- 169
- References
- 288
- Citations by year
- 2026: 4 · 2025: 17 · 2024: 10 · 2023: 9 · 2022: 8 · 2021: 7 · 2020: 13 · 2019: 10 · 2018: 9 · 2017: 10 · 2016: 13 · 2015: 15 · 2014: 12 · 2013: 12 · 2012: 12
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- major depressive disorder, cardiovascular disease, inflammatory signaling, oxidative stress, nitrosative stress, inflammatory cytokines, acute phase proteins, complement system, lipopolysaccharide, tryptophan catabolites, indoleamine 2,3-dioxygenase, antioxidants, atherosclerosis, omega-3 polyunsaturated fatty acids, cardiovascular mortality, Charlson Comorbidity Index
- MeSH terms
- Animals, Antioxidants, Cardiovascular Diseases, Depression, Female, Humans, Inflammation, Male, Risk, Fatty Acids, Omega-3, Nitrosation, Comorbidity, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review